 

 

AL'OW‘ A ‘ ' _.

PART ‘I: LYMPH NODE, RIGHT AXILLA #‘I SENTINEL, BIOPSY -

 

A,~ ONE (1) LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA (111).
B, METASTATIC TUMOR MEASURES 0.5 CM.

Am . : mu DE, RIGHT AXILLA #2 SENTINEL, BIOPSY -
B" 2.: 0.15713 LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA (1m.
-. ,~. d; LETASTATIC FOCUS MEASURES 1.1 CM.

1 S: EXTRACAPSULAR EXTENSION IS IDENTIFIED.

«PART ‘ _, BREAST ASTECTOMY —'
' 3: »- ' ' R“; FnggﬁLlNT/ASIVE 0991A]. CARCINOMA wITH APOCRINE FEATURES, NOTTINGHAM SCORE

BULES - 2, NUCLEAR GRADE — 3, ). . ’
ﬁEnLtARGER INVASIVE TUMOR MEASURES 2.4 CM, AND IS LOCATED AT 9.00 O CLOCK POSITION.

BL T 12 O’CLOCK POSITION.
I VASIVE TUMOR MEASURES 1.1 CM, AND LOCATED A .
g: DUEﬂTC-AERZIN‘OMA IN SITU (DCIS), NUCLEAR GRADE 3, APOCRINE AND SOLID TYPES WITH COMEDO
~' NECROSIS.
MOR MASS AND IS PRESENT
. CARCINOMA IN SITU CONSTITUTES 20% OF THE TOTAL TU

E ggﬁIﬁ-D WITH AND AWAY FROM THE INVASIVE COMPONENT (UPPER OUTER QUADRANT).

F. LYMPHOVASCULAR INVASION ls IDENTIFIED.

G. ALL SURGICAL MARGINS OF RESECTION ARE FREE OF TUMOR.

H. NIPPLE IS FREE OF TURM‘RJI?‘i OR

TIVE FO .

II. ifézgcgig$ICATIONs ARE PRESENT IN ASSOCIATION WITH DCIS AND INVASIVE CARCINOMA.

K. NON-NEOPLASTIC BREAST PARENCHYMA WITH FIBROCYSTIC CHANGES.

L. ER POSITIVE, PR POSITIVE, HER-ZINEU POSITIVE 3+ , ,
' : MPH NODES, RIGHT AXILLARY, DISSECTION - CINOMA 1I17).

PART 4 ALY ONE (1) OF SEVENTEEN LYMPH NODE POSITIVE FOR MlEnTASTATIC CAR (
B. FOCUS OF METASTATIC CARCINOMA MEASURES 1.3 C . /CA , d / 3
c: EXTRACAPSULAR EXTENSION I_S IDENTIFIED. K ‘ J 850
VHS: STNUFSIS: 6W. mic/MW; dad ,Na; 0 a
a¥gglﬁfvaMARY INVASIVE CARgilglngA OF BREAST 5].”: W Am Cw ’ 9 3/13/11 A1
PROCEDURE: Modiﬁed radical mastectomy
LOCATION: Upper outer quadrant
Lower inner quadrant
SIZE OF TUMOR: ' Maximum dimension invasive component: 2.4 cm
MULTICENTRICITYIMULTIFOCALITY OF INVASIVE FOCI:
Yes

TUMOR AGGREGATE SIZE: Sum Of the sizes of multiple invasive tumors: 3.5 cm

TUMOR TYPE (invasive component):
Ductal adenocarcinoma, NOS

NOTTINGHAM SCORE: ﬁgﬁgggﬁg: 2 ”Um#2253333113353‘173331”:Enﬂ‘aﬂﬁgecda cted
M“°“° “IV“ we: 3 , III I ii i Ill i ii I lllllllllllllllllll ll |||l||||l|||||Illlllllhlﬂlllﬂlll
ngggggggcgg‘ejerg 33). 3 III |||IlllllllllllllllllllllllllllllllllIllllnlllllﬂlllllllhlhlmm

ANGIOLYMPHATIC INVASION: Yes ' ' ' Ill IIIIIIIIIII|"IilllIlllIIIIllIIIIIlIHIII

DERMAL LYMPHATIC INVASION: No '

CALCIFICATION: Yes, malignant zones

TUMOR TYPE, IN SITU: Solid, Apocrine, DCIS admixed and outside of invasive carcinoma component, Ductal

SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT:
NO
SURG MARGINS INVOLVED BY IN SITU COMPONENT:

 

No
PAGET'S DISEASE OF NIPPLE: No
LYMPH NODES POSITIVE: m,
LYMPH NODES EXAMINED: 19 Review
METHOD(S) OF LYMPH NODE EXAMINATION:
H/E stain

SENTINEL NODE METASTASIS: Yes
ONLY KERATIN POSITIVE CELLS ARE PRESENT:
No
SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 1.3 mm
LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION:

Yes
METASTASES TO IPSILATERAL INTERNAL MAMMARY LYMPH NODE (IF APPLICABLE):
o .

N
SKIN INVOLVED (ULCERATION): No
NON-NEOPLASTIC BREAST TISSUE: FCD
T STAGE, PATHOLOGIC: pT2
N STAGE, PATHOLOGIC: pN1a
M STAGE, PATHOLOGIC: ""V

